These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17894944)

  • 1. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
    Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
    Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
    Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
    Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
    Xiao H; Hasegawa T; Isobe K
    J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
    Zelko IN; Folz RJ
    Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
    Wooten LG; Ogretmen B
    J Biol Chem; 2005 Aug; 280(32):28867-76. PubMed ID: 15951564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
    Mikkelsen IM; Huseby NE; Visvikis A; Moens U
    Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.
    Zhang Y; Liao M; Dufau ML
    Mol Cell Biol; 2006 Sep; 26(18):6748-61. PubMed ID: 16943418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
    Bu Y; Gelman IH
    J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
    Walker GE; Wilson EM; Powell D; Oh Y
    Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GC-rich sequences in the 5-lipoxygenase gene promoter are required for expression in Mono Mac 6 cells, characterization of a novel Sp1 binding site.
    Dishart D; Schnur N; Klan N; Werz O; Steinhilber D; Samuelsson B; Rådmark O
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):37-47. PubMed ID: 16413224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.